Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
377.48B | 356.01B | 339.66B | 340.80B | 338.46B | Gross Profit |
105.84B | 100.95B | 102.26B | 100.13B | 99.81B | EBIT |
7.89B | 10.39B | 8.35B | 6.66B | 9.37B | EBITDA |
12.31B | 15.09B | 13.32B | 11.10B | 13.64B | Net Income Common Stockholders |
3.61B | 6.19B | 4.71B | 3.83B | 5.85B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.37B | 3.84B | 3.90B | 3.77B | 6.30B | Total Assets |
187.26B | 156.27B | 152.97B | 152.09B | 144.26B | Total Debt |
46.44B | 29.09B | 29.63B | 35.53B | 19.93B | Net Debt |
42.07B | 25.25B | 25.73B | 31.76B | 13.62B | Total Liabilities |
114.20B | 84.61B | 85.81B | 88.02B | 82.39B | Stockholders Equity |
73.06B | 71.67B | 67.16B | 64.08B | 61.87B |
Cash Flow | Free Cash Flow | |||
-4.94B | 4.04B | 6.19B | -12.79B | 6.90B | Operating Cash Flow |
12.87B | 12.23B | 14.88B | 868.00M | 13.68B | Investing Cash Flow |
-34.00B | -7.86B | -8.81B | -13.53B | -7.05B | Financing Cash Flow |
21.67B | -4.43B | -5.94B | 10.13B | -4.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥102.90B | 11.09 | 2.43% | 4.31% | 21.77% | ||
73 Outperform | ¥91.96B | 14.92 | 1.70% | 4.17% | -13.52% | ||
71 Outperform | ¥232.37B | 19.51 | 2.77% | 11.24% | -41.84% | ||
70 Outperform | ¥123.21B | 34.22 | 1.80% | 6.03% | -41.79% | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
62 Neutral | ¥179.75B | 168.91 | 1.74% | 14.80% | -135.81% | ||
58 Neutral | ¥173.89B | 45.54 | 1.50% | 0.99% | -48.66% |